# Nexien BioPharma, Inc. (NXEN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NXEN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -30.8K | $ -13.3K | $ 375.4K | $ -450.5K |
| 2024 | $ 0 | $ -221.9K | $ -73.3K | $ 351.0K | $ -422.69B |
| 2023 | $ 0 | $ 88.93B | $ -71.8K | $ 280.5K | $ -314.2K |
| 2022 | $ 0 | $ -527.8K | $ -103.8K | $ 213.0K | $ -202.3K |
| 2021 | $ 0 | $ -371.8K | $ -95.3K | $ 23.8K | $ -62.4K |
| 2020 | $ 0 | $ -3.98M | $ -115.2K | $ 27.7K | $ 23.8K |
| 2019 | $ 0 | $ -3.85M | $ -452.0K | $ 0 | $ 128.3K |
| 2018 | $ 0 | $ -4.34M | $ -1.08M | $ 0 | $ 845.1K |
| 2017 | $ 0 | $ -1.11M | $ -970.7K | $ 0 | $ 1.11M |
| 2016 | $ 0 | $ -29.6K | $ -34.4K | $ 0 | $ -81.4K |
| 2015 | $ 0 | $ -26.8K | $ -65.6K | $ 0 | $ -59.9K |
| 2014 | $ 0 | $ -57.0K | $ -57.7K | $ 0 | $ -40.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.83 |
| Liabilities / Eq | -1.02 |
| Current Ratio | 0.02 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/NXEN.md)
- [Charts](https://sponda.capital/en/NXEN/charts.md)
- [Compare](https://sponda.capital/en/NXEN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.